DE60332321D1 - Ultrafeine zusammensetzungen von formoterol - Google Patents

Ultrafeine zusammensetzungen von formoterol

Info

Publication number: DE60332321D1
Authority: DE; Germany
Prior art keywords: formoterol; ultrafine; compositions; ultrafine compositions
Prior art date: 2002-03-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60332321T

Other languages

English (en)

Inventor

Rebecca Jaine Davies

David Ganderton

David Andrew Lewis

Brian John Meakin

Tanya Kathleen Church

Gaetano Brambilla

Alessandra Ferraris

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chiesi Farmaceutici SpA

Original Assignee

Chiesi Farmaceutici SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-01

Filing date

2003-02-26

Publication date

2010-06-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27790093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60332321(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-01 Priority claimed from EP02004786A external-priority patent/EP1340492A1/de

2002-10-23 Priority claimed from EP02023589A external-priority patent/EP1415647A1/de

2003-02-26 Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA

2010-06-10 Application granted granted Critical

2010-06-10 Publication of DE60332321D1 publication Critical patent/DE60332321D1/de

2023-02-27 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

DE60332321T 2002-03-01 2003-02-26 Ultrafeine zusammensetzungen von formoterol Expired - Lifetime DE60332321D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02004786A EP1340492A1 (de)	2002-03-01	2002-03-01	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
EP02023589A EP1415647A1 (de)	2002-10-23	2002-10-23	Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
PCT/EP2003/001964 WO2003074024A1 (en)	2002-03-01	2003-02-26	Formoterol superfine formulation

Publications (1)

Publication Number	Publication Date
DE60332321D1 true DE60332321D1 (de)	2010-06-10

Family

ID=27790093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60332321T Expired - Lifetime DE60332321D1 (de)	2002-03-01	2003-02-26	Ultrafeine zusammensetzungen von formoterol

Country Status (36)

Country	Link
US (4)	US20050152846A1 (de)
EP (6)	EP3494995B1 (de)
JP (3)	JP2005523905A (de)
KR (2)	KR100947409B1 (de)
CN (2)	CN100398094C (de)
AR (2)	AR038644A1 (de)
AT (1)	ATE465712T1 (de)
AU (2)	AU2003222753B2 (de)
BR (2)	BRPI0308274B8 (de)
CA (2)	CA2477881C (de)
CO (2)	CO5611091A2 (de)
CY (4)	CY1111133T1 (de)
DE (1)	DE60332321D1 (de)
DK (4)	DK3536344T3 (de)
EA (2)	EA007735B1 (de)
ES (4)	ES2342463T3 (de)
GE (2)	GEP20063986B (de)
HK (1)	HK1079425A1 (de)
HR (2)	HRP20040753A2 (de)
HU (3)	HUE044926T2 (de)
IL (3)	IL163843A0 (de)
LT (3)	LT3384931T (de)
MA (1)	MA27175A1 (de)
ME (3)	ME00077B (de)
MX (2)	MXPA04008372A (de)
MY (2)	MY137603A (de)
NO (2)	NO20043625L (de)
NZ (2)	NZ535018A (de)
PE (2)	PE20030824A1 (de)
PL (2)	PL209212B1 (de)
PT (4)	PT3384931T (de)
RS (2)	RS52387B (de)
SI (4)	SI1480615T1 (de)
TN (2)	TNSN04149A1 (de)
TW (2)	TWI347197B (de)
WO (2)	WO2003074024A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6315985B1 (en) *	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1317720B1 (it) *	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) *	2000-05-22	2004-07-01	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
CZ301676B6 (cs) *	2001-03-30	2010-05-19	Jagotec Ag	Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny
SI1273292T1 (en) *	2001-07-02	2004-12-31	Chiesi Farmaceutici S.P.A.	Optimised formulation of tobramycin for aerosolization
EP1415647A1 (de) *	2002-10-23	2004-05-06	CHIESI FARMACEUTICI S.p.A.	Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
EP1340492A1 (de) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
SI1480615T1 (sl) *	2002-03-01	2010-07-30	Chiesi Farma Spa	Superfina formulacija formoterola
EP1452179A1 (de) *	2003-02-27	2004-09-01	CHIESI FARMACEUTICI S.p.A.	Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
ATE526967T1 (de) *	2003-07-31	2011-10-15	Boehringer Ingelheim Int	Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323684D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
KR20070000476A (ko) *	2004-02-27	2007-01-02	키에시 파르마슈티시 엣스. 피. 에이.	압축화 계량된 도스흡입용 안정된 약제용액 제제
EP1595531A1 (de) *	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stabile Arzneimittellösung für Druckdosierinhalatoren
UA88894C2 (ru) *	2004-02-27	2009-12-10	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением
DE602005008946D1 (de) *	2004-05-13	2008-09-25	Chiesi Farma Spa	Medizinische aerosolformulierungen mit verbesserter chemischer stabilität
EA013428B1 (ru) *	2004-07-02	2010-04-30	Бёрингер Ингельхайм Интернациональ Гмбх	РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
GB0420722D0 (en) *	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
NZ556376A (en) *	2005-02-25	2010-01-29	Chiesi Farma Spa	Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
DE102006017320A1 (de) *	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP1982709A1 (de)	2007-04-19	2008-10-22	CHIESI FARMACEUTICI S.p.A.	Verwendung einer Zusammensetzung mit Formoterol und Beclomethason-Dipropionat zur Vorbeugung oder Behandlung von akutem Asthma
EP2100598A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
GB2461752B (en) *	2008-07-14	2013-04-17	Neo Inhalation Products Ltd	Metered dose inhaler
EP2355808A4 (de) *	2008-10-23	2012-04-25	Sunovion Pharmaceuticals Inc	Arformoterol- und tiotropium-zusammensetzungen sowie verwendungsverfahren
GB0918149D0 (en)	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
AU2010334859A1 (en)	2009-12-23	2012-07-12	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD
CA2785317C (en)	2009-12-23	2018-02-27	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
EP2360147A1 (de) *	2010-02-22	2011-08-24	CHIESI FARMACEUTICI S.p.A.	Verfahren zur Herstellung von kristallinen Partikeln von einem Salz von 8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-chinolinon (Carmoterol)
BR112013001119A2 (pt) *	2010-07-16	2016-05-24	Cipla Ltd	composição farmacêutica, processo para fabricar uma composição farmacêutica, uso de r(+)budesonida e um broncodilatador, e método de profilaxia ou tratamento de uma doença respiratória, inflamatória ou obstrutiva das vias aéreas
TWI399202B (zh)	2011-03-17	2013-06-21	Intech Biopharm Ltd	製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2510928A1 (de)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
WO2014076250A1 (en) *	2012-11-15	2014-05-22	Löndahl Jakob	Device and method for pulmonary function measurement
RU2504402C1 (ru) *	2012-11-20	2014-01-20	Шолекс Девелопмент Гмбх	Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
CN106667973A (zh) *	2017-01-22	2017-05-17	西咸新区世云工研坊生物科技有限公司	一种用于防雾霾损伤的组合物及其制备方法和喷剂
KR20220133193A (ko)	2020-01-28	2022-10-04	키에시 파르마슈티시 엣스. 피. 에이.	완충된 약제학적 제제를 포함하는 가압 정량 흡입기
EP4106722A1 (de)	2020-02-20	2022-12-28	Chiesi Farmaceutici S.p.A.	Unter druck stehende inhalatoren mit abgemessener dosis mit einer gepufferten pharmazeutischen formulierung
WO2023227783A1 (en)	2022-05-27	2023-11-30	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3361306A (en) *	1966-03-31	1968-01-02	Merck & Co Inc	Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) *	1969-12-10	1971-11-23	Schering Corp	Aerosol inhaler with flip-up nozzle
US4185100A (en) *	1976-05-13	1980-01-22	Johnson & Johnson	Topical anti-inflammatory drug therapy
US4499108A (en) *	1983-06-08	1985-02-12	Schering Corporation	Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) *	1983-12-24	1984-02-01	Tanabe Seiyaku Co	Carbostyril derivatives
IT1196142B (it) *	1984-06-11	1988-11-10	Sicor Spa	Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) *	1985-01-03	1986-04-22	David Rubin	Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) *	1985-05-22	1993-03-09	Liposome Technology, Inc.	Corticosteroid inhalation treatment method
US5225183A (en) *	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
IT1244441B (it) *	1990-09-13	1994-07-15	Chiesi Farma Spa	Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) *	1990-12-21	1999-12-28	Minnesota Mining And Manufacturing Company	Device for delivering an aerosol
US5190029A (en) *	1991-02-14	1993-03-02	Virginia Commonwealth University	Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US6299863B1 (en) *	1992-04-03	2001-10-09	Sepracor Inc.	Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
PL169046B1 (pl) *	1991-08-29	1996-05-31	Christoph Klein	Przyrzad medyczny do inhalacji aerozolem PL PL PL PL PL
DE4230876A1 (de) *	1992-03-17	1993-09-23	Asta Medica Ag	Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
SK280911B6 (sk) *	1992-12-09	2000-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Farmaceutický prostriedok
ZA939195B (en) *	1992-12-09	1995-06-08	Boehringer Ingelheim Pharma	Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) *	1992-12-11	1992-12-11	Astra Ab	Efficient use
US5899201A (en) *	1993-05-26	1999-05-04	Minnesota Mining And Manufacturing Company	Aerosol actuator
PT735884E (pt) *	1993-12-20	2000-09-29	Minnesota Mining & Mfg	Formulacoes de aerossol de flunisolida
US5508269A (en) *	1994-10-19	1996-04-16	Pathogenesis Corporation	Aminoglycoside formulation for aerosolization
US5653961A (en) *	1995-03-31	1997-08-05	Minnesota Mining And Manufacturing Company	Butixocort aerosol formulations in hydrofluorocarbon propellant
ATE373613T1 (de) *	1995-04-14	2007-10-15	Smithkline Beecham Corp	Verfahren zur herstellung eines dosierinhalators
TR199701168T1 (xx) *	1995-04-14	1998-05-21	Glaxo Wellcome Inc.	Flutikazon Propionat i�in �l��lm�� doz inhaleri.
US5637505A (en) *	1995-05-19	1997-06-10	Chiron Diagnostics Corporation	Method to prepare dye-based reference material
EP0943330A4 (de) *	1996-10-04	2001-08-16	Saitama Daiichi Seiyaku Kabush	Pflaster
US6040344A (en) *	1996-11-11	2000-03-21	Sepracor Inc.	Formoterol process
US6413496B1 (en) *	1996-12-04	2002-07-02	Biogland Ireland (R&D) Limited	Pharmaceutical compositions and devices for their administration
JP2001511160A (ja) *	1997-02-05	2001-08-07	ヤゴリサーチアクチェンゲゼルシャフト	医学用エアゾール配合物
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) *	1997-04-21	1999-04-06	Aeropharm Technology Limited	Environmentally safe flunisolide aerosol formulations for oral inhalation
US6188933B1 (en) *	1997-05-12	2001-02-13	Light & Sound Design Ltd.	Electronically controlled stage lighting system
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
GB2326334A (en)	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
NZ504021A (en) *	1997-10-17	2003-04-29	Systemic Pulmonary Delivery Lt	Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) *	1998-05-07	2000-04-04	The Procter & Gamble Company	Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
EP1100465B1 (de)	1998-07-24	2004-11-24	Jago Research Ag	Medizinische aerosolformulierungen
EP1102579B1 (de) *	1998-08-04	2003-03-19	Jago Research Ag	Medizinische aerosolformulierungen
DE19847969A1 (de) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähig flüssige Formulierung mit Formoterol
US7521068B2 (en)	1998-11-12	2009-04-21	Elan Pharma International Ltd.	Dry powder aerosols of nanoparticulate drugs
HU226164B1 (en) *	1998-11-13	2008-05-28	Jagotec Ag	Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
US6352152B1 (en) *	1998-12-18	2002-03-05	Smithkline Beecham Corporation	Method and package for storing a pressurized container containing a drug
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) *	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
GB9904919D0 (en) *	1999-03-03	1999-04-28	Novartis Ag	Organic compounds
US6315985B1 (en) *	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AU7026800A (en) *	1999-09-11	2001-04-17	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
GB9928311D0 (en) *	1999-11-30	2000-01-26	Novartis Ag	Organic compounds
US6578125B2 (en)	2000-02-14	2003-06-10	Sanyo Electric Co., Ltd.	Memory access circuit and memory access control circuit
IT1317846B1 (it) *	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008660D0 (en) *	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
GB0009773D0 (en)	2000-04-19	2000-06-07	Univ Cardiff	Particulate composition
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) *	2000-05-22	2004-07-01	Chiesi Farmaceutici S.P.A.	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
EP1241113A1 (de)	2001-03-12	2002-09-18	CHIESI FARMACEUTICI S.p.A.	Inhalator mit Mitteln um chemische Stabilität der darin enthaltenen medizinischen Aerosollösung zu verbessern
SI1273292T1 (en) *	2001-07-02	2004-12-31	Chiesi Farmaceutici S.P.A.	Optimised formulation of tobramycin for aerosolization
EP1340492A1 (de) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
SI1480615T1 (sl) *	2002-03-01	2010-07-30	Chiesi Farma Spa	Superfina formulacija formoterola
EP1595531A1 (de) *	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stabile Arzneimittellösung für Druckdosierinhalatoren

2003
- 2003-02-26 SI SI200331813T patent/SI1480615T1/sl unknown
- 2003-02-26 HU HUE18173392 patent/HUE044926T2/hu unknown
- 2003-02-26 EP EP19166324.4A patent/EP3494995B1/de not_active Expired - Lifetime
- 2003-02-26 KR KR1020047013491A patent/KR100947409B1/ko active IP Right Grant
- 2003-02-26 DE DE60332321T patent/DE60332321D1/de not_active Expired - Lifetime
- 2003-02-26 EP EP10156461.5A patent/EP2201964B1/de not_active Expired - Lifetime
- 2003-02-26 SI SI200332607T patent/SI3536344T1/sl unknown
- 2003-02-26 PT PT18173392T patent/PT3384931T/pt unknown
- 2003-02-26 BR BRPI0308274A patent/BRPI0308274B8/pt active IP Right Grant
- 2003-02-26 GE GEAP8391A patent/GEP20063986B/en unknown
- 2003-02-26 LT LTEP18173392.4T patent/LT3384931T/lt unknown
- 2003-02-26 WO PCT/EP2003/001964 patent/WO2003074024A1/en active Application Filing
- 2003-02-26 ES ES03718677T patent/ES2342463T3/es not_active Expired - Lifetime
- 2003-02-26 EP EP03718677A patent/EP1480615B1/de not_active Expired - Lifetime
- 2003-02-26 JP JP2003572544A patent/JP2005523905A/ja active Pending
- 2003-02-26 EP EP19171326.2A patent/EP3536344B1/de not_active Expired - Lifetime
- 2003-02-26 LT LTEP19171326.2T patent/LT3536344T/lt unknown
- 2003-02-26 DK DK19171326.2T patent/DK3536344T3/da active
- 2003-02-26 HU HUE19166324A patent/HUE049426T2/hu unknown
- 2003-02-26 ME MEP-2008-301A patent/ME00077B/me unknown
- 2003-02-26 DK DK18173392.4T patent/DK3384931T3/da active
- 2003-02-26 NZ NZ535018A patent/NZ535018A/en not_active IP Right Cessation
- 2003-02-26 CA CA2477881A patent/CA2477881C/en not_active Expired - Lifetime
- 2003-02-26 US US10/504,151 patent/US20050152846A1/en not_active Abandoned
- 2003-02-26 AT AT03718677T patent/ATE465712T1/de active
- 2003-02-26 EA EA200401007A patent/EA007735B1/ru not_active IP Right Cessation
- 2003-02-26 PT PT191663244T patent/PT3494995T/pt unknown
- 2003-02-26 EP EP18173392.4A patent/EP3384931B1/de not_active Expired - Lifetime
- 2003-02-26 DK DK19166324.4T patent/DK3494995T3/da active
- 2003-02-26 ES ES19166324T patent/ES2780127T3/es not_active Expired - Lifetime
- 2003-02-26 ES ES18173392T patent/ES2745064T3/es not_active Expired - Lifetime
- 2003-02-26 HU HUE19171326A patent/HUE048310T2/hu unknown
- 2003-02-26 IL IL16384303A patent/IL163843A0/xx unknown
- 2003-02-26 ES ES19171326T patent/ES2779273T3/es not_active Expired - Lifetime
- 2003-02-26 PL PL372173A patent/PL209212B1/pl unknown
- 2003-02-26 ME MEP-301/08A patent/MEP30108A/xx unknown
- 2003-02-26 AU AU2003222753A patent/AU2003222753B2/en not_active Expired
- 2003-02-26 DK DK03718677.2T patent/DK1480615T3/da active
- 2003-02-26 RS YU76704A patent/RS52387B/en unknown
- 2003-02-26 SI SI200332611T patent/SI3494995T1/sl unknown
- 2003-02-26 PT PT191713262T patent/PT3536344T/pt unknown
- 2003-02-26 SI SI200332600T patent/SI3384931T1/sl unknown
- 2003-02-26 PT PT03718677T patent/PT1480615E/pt unknown
- 2003-02-26 LT LTEP19166324.4T patent/LT3494995T/lt unknown
- 2003-02-26 MX MXPA04008372A patent/MXPA04008372A/es active IP Right Grant
- 2003-02-26 CN CNB038049767A patent/CN100398094C/zh not_active Expired - Lifetime
- 2003-02-27 PL PL03372292A patent/PL372292A1/xx not_active Application Discontinuation
- 2003-02-27 CN CNA038049724A patent/CN1638729A/zh active Pending
- 2003-02-27 KR KR1020047013502A patent/KR100961603B1/ko not_active IP Right Cessation
- 2003-02-27 CA CA2477885A patent/CA2477885C/en not_active Expired - Fee Related
- 2003-02-27 TW TW092104192A patent/TWI347197B/zh not_active IP Right Cessation
- 2003-02-27 TW TW092104191A patent/TW200303752A/zh unknown
- 2003-02-27 IL IL16384403A patent/IL163844A0/xx unknown
- 2003-02-27 GE GEAP8392A patent/GEP20063876B/en unknown
- 2003-02-27 RS YU76604A patent/RS76604A/sr unknown
- 2003-02-27 AU AU2003210370A patent/AU2003210370C1/en not_active Ceased
- 2003-02-27 NZ NZ535017A patent/NZ535017A/en not_active IP Right Cessation
- 2003-02-27 EP EP03743343A patent/EP1480617A2/de not_active Withdrawn
- 2003-02-27 EA EA200401005A patent/EA008592B1/ru not_active IP Right Cessation
- 2003-02-27 WO PCT/EP2003/002004 patent/WO2003074025A2/en active Application Filing
- 2003-02-27 BR BR0308275-0A patent/BR0308275A/pt not_active IP Right Cessation
- 2003-02-27 US US10/505,861 patent/US20050154013A1/en not_active Abandoned
- 2003-02-27 JP JP2003572545A patent/JP2005524664A/ja not_active Withdrawn
- 2003-02-27 MX MXPA04008369A patent/MXPA04008369A/es not_active Application Discontinuation
- 2003-02-27 ME MEP-302/08A patent/MEP30208A/xx unknown
- 2003-02-28 AR ARP030100687A patent/AR038644A1/es unknown
- 2003-02-28 PE PE2003000199A patent/PE20030824A1/es active IP Right Grant
- 2003-02-28 PE PE2003000202A patent/PE20030827A1/es not_active Application Discontinuation
- 2003-02-28 MY MYPI20030711A patent/MY137603A/en unknown
- 2003-02-28 AR ARP030100684A patent/AR038641A1/es not_active Application Discontinuation
- 2003-02-28 MY MYPI20030710A patent/MY143517A/en unknown
2004
- 2004-08-06 TN TNP2004000149A patent/TNSN04149A1/en unknown
- 2004-08-06 TN TNP2004000147A patent/TNSN04147A1/en unknown
- 2004-08-09 MA MA27817A patent/MA27175A1/fr unknown
- 2004-08-20 HR HRP20040753 patent/HRP20040753A2/xx not_active Application Discontinuation
- 2004-08-20 HR HRP20040752AA patent/HRP20040752B1/hr not_active IP Right Cessation
- 2004-08-27 CO CO04084184A patent/CO5611091A2/es not_active Application Discontinuation
- 2004-08-27 CO CO04084191A patent/CO5611092A2/es not_active Application Discontinuation
- 2004-08-31 NO NO20043625A patent/NO20043625L/no not_active Application Discontinuation
- 2004-08-31 NO NO20043626A patent/NO342575B1/no not_active IP Right Cessation
- 2004-08-31 IL IL163843A patent/IL163843A/en active IP Right Grant
2005
- 2005-12-12 HK HK05111376.6A patent/HK1079425A1/xx not_active IP Right Cessation
2009
- 2009-06-19 US US12/487,988 patent/US20090263488A1/en not_active Abandoned
2010
- 2010-05-06 JP JP2010106449A patent/JP2010215637A/ja not_active Withdrawn
- 2010-06-18 CY CY20101100567T patent/CY1111133T1/el unknown
- 2010-09-01 US US12/873,690 patent/US8313732B2/en not_active Expired - Lifetime
2019
- 2019-09-10 CY CY20191100946T patent/CY1122027T1/el unknown
2020
- 2020-03-16 CY CY20201100231T patent/CY1122851T1/el unknown
- 2020-03-16 CY CY20201100230T patent/CY1122875T1/el unknown

Also Published As

Publication number	Publication date
PT3384931T (pt)	2019-09-26
CO5611091A2 (es)	2006-02-28
GEP20063986B (en)	2006-12-11
MEP30108A (en)	2010-06-10
KR100947409B1 (ko)	2010-03-12
TW200303752A (en)	2003-09-16
HUE044926T2 (hu)	2019-11-28
SI3536344T1 (sl)	2020-06-30
TW200303767A (en)	2003-09-16
CN1638730A (zh)	2005-07-13
HRP20040752A2 (en)	2004-12-31
US20090263488A1 (en)	2009-10-22
MY137603A (en)	2009-02-27
HUE048310T2 (hu)	2020-07-28
EP1480615A1 (de)	2004-12-01
PL372292A1 (en)	2005-07-11
KR20040093080A (ko)	2004-11-04
HRP20040753A2 (en)	2004-12-31
GEP20063876B (en)	2006-07-10
ES2342463T3 (es)	2010-07-07
MXPA04008372A (es)	2004-11-26
CY1111133T1 (el)	2015-06-11
ES2780127T3 (es)	2020-08-24
IL163843A0 (en)	2005-12-18
NO20043625L (no)	2004-09-29
MEP30208A (en)	2010-10-10
IL163844A0 (en)	2005-12-18
PE20030824A1 (es)	2003-11-07
MXPA04008369A (es)	2004-11-26
TWI347197B (en)	2011-08-21
RS52387B (en)	2013-02-28
TNSN04147A1 (en)	2007-03-12
BR0308274A (pt)	2004-12-28
MY143517A (en)	2011-05-31
BRPI0308274B1 (pt)	2018-10-30
TNSN04149A1 (en)	2007-03-12
AU2003210370B2 (en)	2007-08-30
CA2477881C (en)	2011-02-01
AU2003222753A1 (en)	2003-09-16
EP1480615B1 (de)	2010-04-28
LT3384931T (lt)	2019-09-25
WO2003074025A3 (en)	2003-12-24
PT1480615E (pt)	2010-06-16
NO342575B1 (no)	2018-06-18
CO5611092A2 (es)	2006-02-28
SI3494995T1 (sl)	2020-08-31
CY1122875T1 (el)	2021-05-05
PE20030827A1 (es)	2003-11-06
EA008592B1 (ru)	2007-06-29
CN1638729A (zh)	2005-07-13
EP3536344B1 (de)	2020-02-19
EP3384931B1 (de)	2019-07-24
EP3536344A1 (de)	2019-09-11
JP2005524664A (ja)	2005-08-18
US20050152846A1 (en)	2005-07-14
DK3494995T3 (da)	2020-03-23
CA2477881A1 (en)	2003-09-12
EA200401005A1 (ru)	2005-08-25
EP2201964A3 (de)	2013-01-23
EP3494995B1 (de)	2020-02-19
JP2005523905A (ja)	2005-08-11
KR100961603B1 (ko)	2010-06-04
EA007735B1 (ru)	2006-12-29
AU2003222753B2 (en)	2008-04-17
DK3536344T3 (da)	2020-03-16
AU2003210370C1 (en)	2008-03-13
SI3384931T1 (sl)	2019-11-29
DK3384931T3 (da)	2019-09-16
IL163843A (en)	2011-08-31
EP2201964A2 (de)	2010-06-30
RS76704A (en)	2007-02-05
CY1122851T1 (el)	2021-05-05
US8313732B2 (en)	2012-11-20
WO2003074024A1 (en)	2003-09-12
CA2477885C (en)	2010-12-21
EP2201964B1 (de)	2018-08-08
ATE465712T1 (de)	2010-05-15
AU2003210370A1 (en)	2003-09-16
LT3494995T (lt)	2020-04-10
RS76604A (en)	2006-10-27
WO2003074025A2 (en)	2003-09-12
ES2779273T3 (es)	2020-08-14
NZ535017A (en)	2007-02-23
AR038644A1 (es)	2005-01-19
PL372173A1 (en)	2005-07-11
CY1122027T1 (el)	2020-10-14
CN100398094C (zh)	2008-07-02
EA200401007A1 (ru)	2005-04-28
US20110061651A1 (en)	2011-03-17
PT3494995T (pt)	2020-03-30
AR038641A1 (es)	2005-01-19
EP3494995A3 (de)	2019-07-24
HK1079425A1 (en)	2006-04-07
HUE049426T2 (hu)	2020-09-28
PT3536344T (pt)	2020-03-26
NZ535018A (en)	2007-02-23
JP2010215637A (ja)	2010-09-30
DK1480615T3 (da)	2010-07-12
NO20043626L (no)	2004-08-31
CA2477885A1 (en)	2003-09-12
EP3384931A1 (de)	2018-10-10
HRP20040752B1 (hr)	2012-10-31
ES2745064T3 (es)	2020-02-27
BRPI0308274B8 (pt)	2021-05-25
EP3494995A2 (de)	2019-06-12
EP1480617A2 (de)	2004-12-01
BR0308275A (pt)	2004-12-28
KR20040093079A (ko)	2004-11-04
PL209212B1 (pl)	2011-08-31
US20050154013A1 (en)	2005-07-14
SI1480615T1 (sl)	2010-07-30
MA27175A1 (fr)	2005-01-03
LT3536344T (lt)	2020-04-10
ME00077B (me)	2010-06-10

Legal Events

Date	Code	Title	Description
2011-04-21	8363	Opposition against the patent

Publication	Publication Date	Title
ATE465712T1 (de)	2010-05-15	Ultrafeine zusammensetzungen von formoterol
ATE350450T1 (de)	2007-01-15	Waschmittelzusammensetzungen und komponenten davon
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
FR2842416B1 (fr)	2004-12-17	Composition cosmetique
DE60325255D1 (de)	2009-01-22	Duftzusammensetzung
DE602004005753D1 (de)	2007-05-16	Kombinationen von harzzusammensetzungen und verwendungsverfahren dafür
DE60328426D1 (de)	2009-08-27	Gestaltung der Verschlusselemente
DE60325153D1 (de)	2009-01-22	Gekapselte Riechstoffzusammensetzungen
DE60312277D1 (de)	2007-04-19	Gekapselte Riechstoffzusammensetzungen
DE60221247D1 (de)	2007-08-30	Schweisshemmende oder deodorierende zusammensetzungen
NO20052278L (no)	2005-06-06	Piperazinyl- og diazapanyl-benzamider og -benztioamider
DE10393374D2 (de)	2005-09-01	Zusammensetzung
DK1425019T3 (da)	2008-02-04	Farmaceutisk sammensætning omfattende et androgen
FI20021660A0 (fi)	2002-09-17	Hiilihydraattien uusi käyttö ja koostumukset
SE0500163L (sv)	2005-01-24	Sammansättning
DE60111430D1 (de)	2005-07-14	Hypochlorige säure zusammensetzung und ihre verwendungen
DE60310914D1 (de)	2007-02-15	Pulverzusammensetzung
DE60316954D1 (de)	2007-11-29	Shampoozusammensetzungen
DE60320902D1 (de)	2008-06-26	Zusammensetzungen mit ausgelöster Freisetzung
DE602004014485D1 (de)	2008-07-31	Zusammensetzung und anwendungen von galectin-antagonisten
DE602004026277D1 (de)	2010-05-12	Elastomerzusammensetzung und haftklebstoffzusammensetzungen
ITMI20021038A0 (it)	2002-05-16	Disposizione di elettrodi
BR0310113B1 (pt)	2013-10-29	Composições pesticidas
DE60207057D1 (de)	2005-12-08	Phytopharmazeutische zusammensetzungen in form von legierungen
NO20044140D0 (no)	2004-09-29	New Composition